Current recommendations for the treatment of preeclampsia;Aktuelle therapieempfehlungen bei präeklampsie

Gynakologisch-geburtshilfliche Rundschau

Volumn 47, Issue 4, 2007, Pages 209-214

  Klockenbusch, W ^a   Schrepfer, F ^a  

^a UNIVERSITY HOSPITAL MÜNSTER   (Germany)

Author keywords

Gestosis; Hypertension; Preeclampsia, therapy

Indexed keywords

ACETYLSALICYLIC ACID; ALPHA TOCOPHEROL; ANTICONVULSIVE AGENT; ANTIHYPERTENSIVE AGENT; ASCORBIC ACID; DIHYDRALAZINE; LABETALOL; MAGNESIUM SULFATE; NIFEDIPINE; PLASMA SUBSTITUTE; STEROID; URAPIDIL;

ANTIHYPERTENSIVE THERAPY; BRAIN HEMORRHAGE; DELIVERY; DISEASE SEVERITY; GESTATIONAL AGE; HELLP SYNDROME; HUMAN; HYPERTENSION; INTRAUTERINE GROWTH RETARDATION; LOW DRUG DOSE; MEDICAL DECISION MAKING; PREECLAMPSIA; PREMATURITY; REVIEW; RISK ASSESSMENT;

FEMALE; GERMANY; HUMANS; PHYSICIAN'S PRACTICE PATTERNS; PRACTICE GUIDELINES; PRE-ECLAMPSIA; PREGNANCY;

EID: 34948839980     PISSN: 10188843     EISSN: None     Source Type: Journal    
DOI: 10.1159/000107261     Document Type: Review

References (45)

1. Waterstone M, Bewley S, Wolfe C: Incidence and predictors of severe obstetric morbidity: case-control study. BMJ 2001;322:1089-1094.
2. Duley L: Maternal mortality associated with hypertensive disorders of pregnancy in Africa, Latin America and the Caribbean. BJOG 1992;99:547-553.
3. Douglas KA, Redman CWG: Eclampsia in the United Kingdom. BMJ 1994;309:1395-1400.
4. Meis PJ, Goldenberg RL, Mercer BM: The preterm prediction study: risk factors for indicated preterm births. Am J Obstet Gynecol 1988;178:562-567.
5. Visser GHA, Huisman A, Saathof PWF, Sinnige HAM: Early fetal growth retardation: obstetric background and recurrence rate. Obstet Gynecol 1986;67:40-43.
6. Ounsted M: The children of women who had hypertension during pregnancy;in Rubin PC (Hrsg): Handbook of Hypertension: Hypertension in Pregnancy. Amsterdam, Elsevier, 1988, pp 341-362.
7. Roberts JM, Lain KY: Recent insights into the pathogenesis of preeclampsia. Placenta 2002;23:359-372.
8. Klockenbusch W, Fischer T (Hrsg): Präeklampsie. Bremen, UNI-MED Science, 2005.
9. Knight M, Duley l, Henderson-Smart GJ, King JF: Antiplatelet agents for preventing and treating pre-eclampsia. Cochrane Database Syst Rev 2000;2:CD000492.
10. Klockenbusch W, Rath W: Prävention der Präeklampsie mit Acetylsalicylsäure - Eine kritische Analyse. Z Geburtsh Neonatol 2002;206:125-130.
11. Chappell LC, Seed PT, Briley AL, Kelly FJ, Lee R, Hunt BJ, Parmar K, Bewley SJ, Shennan AH, Steer PJ, Poston L: Effect of antioxidants on the occurrence of pre-eclampsia in women at increased risk: a randomised trial. Lancet 1999;354:810-816.
12. Poston L, Briley AI, Seed PT, Kelly FJ, Shennan AH: Vitamin C and vitamin E in pregnant women at risk for pre-eclampsia (VIP trial): randomised placebo-controlled trial. Lancet 2006;367:1145-1154.
13. Rumbold AR, Crowther CA, Haslam RR, Dekker GA, Robinson JS: Vitamins C and E and the risks of preeclampsia and perinatal complications. N Engl J Med 2006;354:1796-1806.
14. Redman CWG, Roberts JM: Management of pre-eclampsia. Lancet 1993;341:1451-1454.
15. Abalos E, Duley L, Steyn DW, Henderson-Smart DJ: Antihypertensive drug therapy for mild to moderate hypertension during pregnancy. Cochrane Database Syst Rev 2001;2:CD002252.
16. Dadelszen von P, Ornstein MP, Bull SB, Logan AG, Koren G, Magee LA: Fall in mean arterial pressure and fetal growth restriction in pregnancy hypertension: a meta-analysis. Lancet 2000;355:87-92.
17. Magee LA, Duley l: Oral beta-blockers for mild to moderate hypertension during pregnancy. Cochrane Database Syst Rev 2003;3:CD002863.
18. Sibai BM: Treatment of hypertension in pregnant women. N Engl J Med 1996;335:257-265.
19. Leveno KJ, Cunningham FG: Management of preeclampsia;in Lindheimer MD, Roberts JM, Cunningham FG (Hrsg): Chesley's Hypertensive Disorders in Pregnancy. Stamford, Appleton & Lange, 1999, pp 543-580.
20. Duley L, Meher S, Abalos E: Management of pre-eclamsia. BMJ 2006;332:463-468.
21. Duley L, Henderson-Smart D: Drugs for rapid treatment of very high blood pressure during pregnancy. Cochrane Database Syst Rev 2002;4:CD001449.
22. Magee LA, Cham C, Waterman EJ, Ohlsson A, von Dadelszen P: Hydralazine for treatment of severe hypertension in pregnancy: meta-analysis. BMJ 2003;327:955-960.
23. Mattar F, Sibai BM: Eclampsia. VIII. Risk factors for maternal morbidity. Am J Obstet Gynecol 2000;182:307-312.
24. Duley L, Galmezoglu AM, Henderson-Smart DJ: Magnesium sulfate and other anticonvulsants for women with preeclampsia. Cochrane Database Syst Rev 2003;2:CD000025.
25. The Magpie Trial Collaborative Group: Do women with pre-eclampsia, and their babies, benefit from magnesium sulphate? The Magpie Trial: a randomised, placebo-controlled trial. Lancet 2002;359:1877-1890.
26. Snyder SW, Cardwell MS: Neuromuscular blockade with magnesium sulfate and nifedipine. Am J Obstet Gynecol 1989;161:35-36.
27. Waisman GD, Mayorga LM, Camera MI, Vignolo CA, Martinotti A: Magnesium plus nifedipine: potentiation of hypotensive effects in preeclampsia? Am J Obstet Gynecol 1988;159:308-309.
28. Magee L, Miremadi S, Li J, Cheng C, Ensom MHH, Carleton B, Cote AM, von Dadelszen P: Therapy with both magnesium sulphate and nifedipine does not increase the risk of serious magnesium-related maternal side-effects in women with preeclampsia. Am J Obstet Gynecol 2005;193:153-163.
29. The Eclampsia Trial Collaborative Group: Which anticonvulsant for women with eclampsia? Evidence from the Collaborative Eclampsia Trial. Lancet 1995;345:1455-1463.
30. Fonseca JE, Mendez F, Catano C, Arias F: Dexamethasone treatment does not improve the outcome of women with HELLP syndrome: a double-blind, placebo-controlled, randomized clinical trial. Am J Obstet Gynecol 2005;193:1591-1598.
31. Barrilleaux PS, Martin JN, Klauser CK, Bufkin L, May WL: Postpartum intravenous dexamethasone for severely preeclamptic patients without hemolysis, elevated liver enzymes, low platelets (HELLP) syndrome: a randomized trial. Obstet Gynecol 2005;105:843-848.
32. Duley L, Williams J, Henderson-Smart DJ: Plasma volume expansion for treatment of pre-eclampsia. Cochrane Database Syst Rev 2002;2:CD001805.
33. Ganzevoort W, Rep A, Bonsel GJ, Fetter WPF, van Sonderen L, De Vries JIP, Wolf H: A randomised controlled trial comparing two temporising management strategies, one with and one without plasma volume expansion, for severe and early onset pre-eclampsia. BJOG 2005;112:1358-1368.
34. Brown MA, Hague WM, Higgins J, Lowe S, McCowan L, Oats J, Peek MJ, Rowan JA, Walters BNJ: The detection, investigation and management of hypertension in pregnancy: full consensus statement. Aust NZ J Obstet Gynaecol 2000;40:139-155.
35. Sibai BM: Diagnosis and management of gestational hypertension and preeclampsia. Obstet Gynecol 2003;102:181-192.
36. ACOG Practice Bulletin No 33: Diagnosis and management of preeclampsia and eclampsia. Obstet Gynecol 2002;99:159-167.
37. Westergaard HB, Langhoff-Roos J, Lingman G, Marsal K, Kreiner S: A critical appraisal of the use of umbilical artery Doppler ultrasound in high-risk pregnancies: use of metaanalyses in evidence-based obstetrics. Ultrasound Obstet Gynecol 2001;17:466-476.
38. Magann EF, Chauhan SP, Kinsella MJ, Mc-Namara MF, Whitworth NS, Morrison JC: Antenatal testing among 1,001 patients at high risk: the role of ultrasonographic estimate of amniotic fluid volume. Am J Obstet Gynecol 1999;180:1330-1336.
39. Odendaal HJ, Pattinson RC, Bam R, Grove D, Kotze TJW: Aggressive or expectant management for patients with severe preeclampsia between 28-34 weeks' gestation: a randomized controlled trial. Obstet Gynecol 1990;76:1070-1075.
40. Sibai BM, Mercer BM, Schiff E, Friedman SA: Aggressive versus expectant management of severe pre-eclampsia at 28 to 32 weeks' gestation: a randomized controlled trial. Am J Obstet Gynecol 1994;171:818-822.
41. Haddad B, Deis S, Goffinet F, Paniel BJ, Cabrol D, Sibai BM: Maternal and perinatal outcomes during expectant management of 239 severe preeclamptic women between 24 and 33 weeks' gestation. Am J Obstet Gynecol 2004;190:1590-1597.
42. Visser W, Wallenburg HCS: Temporising management of severe pre-eclampsia with and without the HELLP syndrome. Br J Obstet Gynaecol 1995;102:111-117.
43. Shear RM, Rinfret D, Leduc L: Should we offer expectant management in cases of severe preterm preeclampsia with fetal growth restriction? Am J Obstet Gynecol 2005;192:1119-1125.
44. Sibai BM, Akl S, Fairlie F, Moretti M: A protocol for managing severe preeclampsia in the second trimester. Am J Obstet Gynecol 1990;163:733-738.
45. Gaugler-Senden IPM, Huijssoon AG, Visser W, Steegers EAP, de Groot CJM: Maternal and perinatal outcome of preeclampsia with an onset before 24 weeks' gestation: audit in a tertiary referral center. Eur J Obstet Gynecol Reprod Biol 2006;128:216-221.